Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.54 |
| ▸ | FAAH | O00519 | 8/20 | 0.48 |
| ▸ | CES1 | P23141 | 5/20 | 0.48 |
| ▸ | CES2 | O00748 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL11435310 | 1.00 | DNM1 (0.54) | DNM1FAAHCES1CES2MEN1 | |
| Trifluoroacetic Acid SCHEMBL3770244 | 0.98 | DNM1 (0.58) | DNM1FAAHCES1CES2MEN1 | |
| Trifluoroacetic Acid SCHEMBL3776886 | 0.92 | FAAH (0.46) | DNM1FAAHCES1CES2MEN1 | |
| Trifluoroacetic Acid SCHEMBL3780749 | 0.92 | FAAH (0.46) | DNM1FAAHCES1CES2MEN1 | |
| Trifluoroacetic Acid SCHEMBL3685262 | 0.92 | DNM1 (0.46) | DNM1FAAHCES1CES2MEN1 | |
| Trifluoroacetic Acid SCHEMBL3773331 | 0.86 | FAAH (0.47) | FAAHCES1CES2MEN1CYP1A2 | |
| Trifluoroacetic Acid SCHEMBL3785764 | 0.86 | FAAH (0.47) | FAAHCES1CES2MEN1CYP1A2 | |
| Bicarbonate SCHEMBL28469661 | 0.85 | DNM1 (0.67) | DNM1CES1CES2CA2CA1 | |
| Oxalic Acid SCHEMBL11422811 | 0.83 | DNM1 (0.64) | DNM1CES1CES2CA2CA1 | |
| Acetic Acid SCHEMBL17839027 | 0.83 | DNM1 (0.64) | DNM1CES1CES2CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8357822-B2 | Process for producing high-purity chlorophosphite | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2013-01-22 | — | — | US | disclosed |
| US-20100324337-A1 | PROCESS FOR PRODUCING HIGH-PURITY CHLOROPHOSPHITE | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324337-A1 | PROCESS FOR PRODUCING HIGH-PURITY CHLOROPHOSPHITE | PHOSPHO1, RPP30, PCBP1 | DNM1 3817/4885FAAH 4169/4885CES1 1776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.